**Core Concept:** Inflammatory Bowel Disease (IBD), mainly Crohn's disease and ulcerative colitis, are chronic inflammatory conditions affecting the gastrointestinal tract. These diseases can extend beyond the gastrointestinal tract causing extra-intestinal manifestations (EIMs) due to shared immunological and inflammatory pathways. EIMs can impact various organ systems, often worsening with disease activity.

**Why the Correct Answer is Right:** Extra-intestinal symptoms like arthralgia, arthritis, and serositis (inflammation of serous membranes) are common in IBD patients, especially during exacerbations of disease activity. These manifestations are likely due to the shared pathophysiology between gut inflammation and systemic inflammation, as well as the activation of immune system components like cytokines and complement pathways.

**Why Each Wrong Option is Incorrect:**

A. **Option A (Anemia):** Although anemia is a common feature in IBD, it does not worsen with disease activity. In fact, anemia in IBD is commonly attributed to chronic blood loss, malabsorption, and inflammation-induced bone marrow suppression.

B. **Option B (Malnutrition):** Malnutrition, typically due to malabsorption and diminished appetite, is a common complication in IBD. However, unlike the correct answer, it does not specifically worsen with disease activity.

C. **Option C (Hepatitis):** Hepatitis is not a common extra-intestinal manifestation of IBD and does not worsen with disease activity. Hepatitis is usually caused by viral infections, alcohol abuse, or autoimmune disorders, not IBD.

D. **Option D (Skin Manifestations):** Extra-intestinal skin manifestations are relatively common in IBD; however, they do not specifically worsen with disease activity. Skin manifestations in IBD can be attributed to systemic inflammation, but their worsening pattern is not as predictable as the correct answer.

**Clinical Pearl:** Understanding the relationship between IBD disease activity and extra-intestinal manifestations is crucial for accurate diagnosis, management, and patient care. Involvement of multiple organs and worsening with disease activity highlights the systemic nature of IBD and the importance of comprehensive evaluation and management of affected patients.